Completed PHASE4 INTERVENTIONAL 2-arm NCT01369667

Vitamin D Supplementation in Adult Crohn's Disease (VITD-CD)

Vitamin D and Immunomodulation: Effects in Crohn's Disease

Sponsor: Queen Mary University of London

Updated 6 times since 2017 Last updated: Aug 15, 2015 Started: Apr 30, 2012 Primary completion: Dec 31, 2014 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01369667, this PHASE4 trial focuses on Crohn's Disease and remains completed. Sponsored by Queen Mary University of London, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Queen Mary University of London
University of Dublin, Trinity College

Data source: University of Dublin, Trinity College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dublin, Ireland